View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Thyroid News

SPONSORED CONTENT
Save
SPONSORED CONTENT
June 20, 2024
3 min read
Save

Patients prefer combined therapy for hypothyroidism, but data reveal few added benefits

Patients prefer combined therapy for hypothyroidism, but data reveal few added benefits

BOSTON — Most adults with hypothyroidism prefer combination therapy with liothyronine plus levothyroxine over levothyroxine alone, but most trials find combination therapy provides limited added benefit, according to two speakers.

SPONSORED CONTENT
June 10, 2024
3 min read
Save

EDC exposures for reproductive-aged women tied to socioeconomic status

EDC exposures for reproductive-aged women tied to socioeconomic status

BOSTON — Pregnant and reproductive-aged women have had recent declines in exposure to most endocrine-disrupting chemicals, though women with a lower socioeconomic status are exposed to higher chemical levels, according to a speaker.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
June 07, 2024
3 min read
Save

Cognitive decline with hypoparathyroidism linked to changes in brain structure

Cognitive decline with hypoparathyroidism linked to changes in brain structure

Adults with hypoparathyroidism experience declines in cognitive function that may be due to structural changes in the brain, according to findings published in the Journal of Bone and Mineral Research.

SPONSORED CONTENT
May 31, 2024
3 min read
Save

New vitamin D consensus guideline, debates highlight ENDO annual meeting

New vitamin D consensus guideline, debates highlight ENDO annual meeting

Endocrinology providers and researchers will gather in Boston beginning Saturday as the Endocrine Society holds its 2024 annual meeting.

SPONSORED CONTENT
May 11, 2024
11 min watch
Save

VIDEO: How endocrinologists can navigate social media

VIDEO: How endocrinologists can navigate social media

NEW ORLEANS — In this video exclusive, Jonathan D. Leffert, MD, talks with Arti Bhan, MD, FACE, and Cheryl Rosenfeld, DO, FACE, FACP, FSVM, ECNUFC, about building a social media presence and talking with patients about social media hype.

SPONSORED CONTENT
May 11, 2024
3 min read
Save

New guidance, technology on the horizon for thyroid nodule risk assessment

New guidance, technology on the horizon for thyroid nodule risk assessment

NEW ORLEANS —New risk stratification guidance for classifying thyroid nodules may come soon as imaging technology continues to evolve, according to a speaker at the AACE annual meeting.

SPONSORED CONTENT
May 09, 2024
4 min read
Save

AI, new technology major focus at 2024 AACE annual meeting

AI, new technology major focus at 2024 AACE annual meeting

Looking to the future will be a key theme at the American Association of Clinical Endocrinology 2024 annual meeting with a keynote lecture focused on AI and sessions examining guidance updates and new technology.

SPONSORED CONTENT
May 06, 2024
2 min read
Save

Subclinical hypothyroidism less likely for men with higher dietary vitamin E intake

Subclinical hypothyroidism less likely for men with higher dietary vitamin E intake

Men who consumed more dietary vitamin E may be less likely to develop subclinical hypothyroidism and autoimmune thyroiditis, though no associations were observed among women, according to findings published in Thyroid.

SPONSORED CONTENT
May 03, 2024
2 min read
Save

GLP-1 receptor agonist tied to similar thyroid cancer risk as DPP-IV, SGLT2 inhibitors

GLP-1 receptor agonist tied to similar thyroid cancer risk as DPP-IV, SGLT2 inhibitors

Adults who initiate a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those prescribed a DPP-IV inhibitor or an SGLT2 inhibitor, according to study findings published in The BMJ.

SPONSORED CONTENT
May 02, 2024
1 min read
Save

FDA fast tracks PTH1 receptor agonist for treatment of hypoparathyroidism

FDA fast tracks PTH1 receptor agonist for treatment of hypoparathyroidism

The FDA granted fast track designation for an investigational parathyroid hormone 1 receptor agonist to treat hypoparathyroidism, according to an industry press release.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails